       |
  |
   |
IN THE NEWS
- Insurance company backs down on mail order pharmacy demand, at least for now
- Valentine’s Kiss from the Government’s HIV Treatment Guidelines Committee
- Development of lersivirine stopped after promising phase 2 results
- Injection-free technique could solve global HIV vaccine challenge
- New 800mg Prezista tablets reduce daily pill count
- New integrase inhibitor dolutegravir suppresses HIV as well as raltegravir
- Smoking cuts lifespan of HIV-positive people by 15 years
- New medication called crofelemer now available for HIV-related diarrhea
- Influential US Task Force now recommends HIV testing for broader portion of Americans
- Encourage USPSTF to change its low grade for testing baby boomers for hepatitis C
- Condom Couture Fashion Show raises nearly $200,000 for critical HIV/AIDS and hepatitis C services!
- Progress and controversies in HIV cure research